DISCONTINUED OPERATIONS (Tables)

9 Months Ended

Sep. 30, 2024

SCHEDULE OF STATEMENT OF OPERATIONS ITEMS TO DISCONTINUED OPERATIONS

The summary of gain (loss) from discontinued operations, net of tax, for the three and nine months ended September 30, 2024 are as follows:

			Three Months Ended September 30, 2024							Nine Months Ended September 30, 2024							Three Months Ended September 30, 2023									Nine Months Ended September 30, 2023
	Qualigen, Inc.		NanoSynex		Total		Qualigen, Inc.			NanoSynex		Total			Qualigen, Inc.		NanoSynex			Total			Qualigen, Inc.			NanoSynex			Total
Loss on disposal of discontinued operations, net of tax	$	—	$	—	$	—	$	—		$	—	$	—		$	90,778	$	68,729		$	159,507		$	(171,701	)	$	(511,307	)	$	(683,008	)
Income (loss) from discontinued operations, net of tax		—		—		—		(100,000	)		—		(100,000	)		3,859,465		(4,479,010	)		(619,545	)		3,859,465			(4,479,010	)		(619,545	)
GAIN (LOSS) FROM DISCONTINUED OPERATIONS	$	—	$	—	$	—	$	(100,000	)	$	—	$	(100,000	)	$	3,950,243	$	(4,410,281	)	$	(460,038	)	$	3,687,764		$	(4,990,317	)	$	(1,302,553	)

NanoSynex [Member]

SCHEDULE OF STATEMENT OF OPERATIONS ITEMS TO DISCONTINUED OPERATIONS

	For the Three Months Ended September 30,			For the Nine Months September 30,
	2023			2023
EXPENSES
Research and development	$	81,640		$	869,064
Total expenses		81,640			869,064
Loss on disposal of discontinued operations		4,479,010			4,479,010
(BENEFIT) PROVISION FOR INCOME TAXES		(150,369	)		(357,757	)
LOSS FROM DISCONTINUED OPERATIONS OF NANOSYNEX, LTD.		(4,410,281	)		(4,990,317	)
Loss attributable to noncontrolling interest		(1,276,969	)		(1,578,481	)
NET LOSS ATTRIBUTABLE TO STOCKHOLDERS	$	(3,133,312	)	$	(3,411,836	)

Parent [Member]

SCHEDULE OF STATEMENT OF OPERATIONS ITEMS TO DISCONTINUED OPERATIONS

The Company reclassified the following statement of operations items to discontinued operations for the three and nine months ended September 30, 2023:

	For the Three Months Ended September 30,		For the Nine Months September 30,
	2023		2023
REVENUES
Net product sales	$	426,920	$	3,661,121
Total revenues		426,920		3,661,121
EXPENSES
Cost of product sales		269,747		2,551,114
General and administrative		26,346		610,559
Research and development		2,612		206,819
Sales and marketing		37,288		405,626
Total expenses		335,993		3,774,118
OTHER EXPENSE (INCOME), NET
Loss on disposal of equipment held for lease		—		63,302
Other expense (income), net		149		(4,898	)
Loss on fixed asset disposal		—		300
Total other expense (income), net		149		58,704
INCOME (LOSS) FROM DISCONTINUED OPERATIONS OF QUALIGEN, INC.		90,778		(171,701	)
Gain on sale of Qualigen, Inc.		3,859,465		3,859,465
INCOME (LOSS) FROM DISCONTINUED OPERATIONS OF QUALIGEN, INC.	$	3,950,243	$	3,687,764